Literature DB >> 21685818

Augmentation index immediately after maximal exercise in patients with type 2 diabetes mellitus.

Julian W Sacre1, David J Holland, Carly Jenkins, James E Sharman.   

Abstract

INTRODUCTION: Patients with type 2 diabetes mellitus (T2DM) have exaggerated brachial and central (ascending aortic) blood pressure (BP) during exercise, which is associated with adverse outcomes. Central systolic loading, represented by the augmentation index (AIx), may contribute to exaggerated exercise central BP. This study sought to compare the central AIx response to peak exercise in T2DM and control patients and to identify mechanisms of altered exercise central AIx.
METHODS: Central BP and AIx were quantified by radial tonometry at rest and immediately after peak treadmill exercise in 106 patients with T2DM and 106 nondiabetic controls, pair-matched by age, gender, peak exercise brachial BP, and postexercise HR corresponding to tonometry acquisition. Cardiac volumes (by echocardiography) were assessed in a subgroup (22 T2DM and 22 controls) to derive rest and postexercise arterial-ventricular coupling parameters, including cardiac index (stroke volume index × HR), peripheral vascular resistance index (cardiac index / mean BP), and effective arterial elastance index (end-systolic pressure / stroke volume index). Reserve parameters (exercise--rest) were also defined.
RESULTS: Patients with T2DM had lower postexercise central AIx (-1% ± 13% vs 3% ± 14%, P = 0.038) and greater central AIx reserve (-24% ± 13% vs -20% ± 11%, P = 0.002) compared with controls, despite raised postexercise peripheral vascular resistance index (P = 0.013) and effective arterial elastance index (P = 0.011); these parameters independently predicted higher central AIx at rest (P < 0.01) but not after exercise. Moreover, T2DM was independently associated with lower postexercise central AIx (β = -0.21, P = 0.006). Cardiac index reserve, which was blunted in T2DM (P = 0.004), represented the only independent correlate of central AIx reserve (r = 0.39, P = 0.01).
CONCLUSIONS: Patients with T2DM have significantly (and paradoxically) lower postexercise central AIx and greater central AIx reserve, which may be explained by an impaired cardiac functional reserve.

Entities:  

Mesh:

Year:  2012        PMID: 21685818     DOI: 10.1249/MSS.0b013e318228588c

Source DB:  PubMed          Journal:  Med Sci Sports Exerc        ISSN: 0195-9131            Impact factor:   5.411


  5 in total

Review 1.  A systematic review on the effect of acute aerobic exercise on arterial stiffness reveals a differential response in the upper and lower arterial segments.

Authors:  Andrew F Mutter; Alexandra B Cooke; Olivier Saleh; Yessica-Haydee Gomez; Stella S Daskalopoulou
Journal:  Hypertens Res       Date:  2016-10-13       Impact factor: 3.872

2.  Effect of acute aerobic exercise and histamine receptor blockade on arterial stiffness in African Americans and Caucasians.

Authors:  Huimin Yan; Sushant M Ranadive; Abbi D Lane-Cordova; Rebecca M Kappus; Michael A Behun; Marc D Cook; Jeffrey A Woods; Kenneth R Wilund; Tracy Baynard; John R Halliwill; Bo Fernhall
Journal:  J Appl Physiol (1985)       Date:  2016-12-15

3.  Central-to-brachial blood pressure amplification in type 2 diabetes: a systematic review and meta-analysis.

Authors:  Rachel E Climie; Martin G Schultz; James W Fell; Lorena Romero; Petr Otahal; James E Sharman
Journal:  J Hum Hypertens       Date:  2018-11-13       Impact factor: 3.012

4.  Acute passive vibration reduces arterial stiffness and aortic wave reflection in stroke survivors.

Authors:  Andrew P Koutnik; Alexei Wong; Roy Kalfon; Takudzwa A Madzima; Arturo Figueroa
Journal:  Eur J Appl Physiol       Date:  2013-10-23       Impact factor: 3.078

5.  Aortic reservoir characteristics and brain structure in people with type 2 diabetes mellitus; a cross sectional study.

Authors:  Rachel E D Climie; Velandai Srikanth; Richard Beare; Laura J Keith; James Fell; Justin E Davies; James E Sharman
Journal:  Cardiovasc Diabetol       Date:  2014-10-23       Impact factor: 9.951

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.